✦ LIBER ✦

Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment

✍ Scribed by Paul Roschger; Inderchand Manjubala; Norbert Zoeger; Florian Meirer; Rolf Simon; Chenghao Li; Nadja Fratzl-Zelman; Barbara M Misof; Eleftherios P Paschalis; Christina Streli; Peter Fratzl; Klaus Klaushofer

Book ID: 111485886
Publisher: American Society for Bone and Mineral Research
Year: 2009
Tongue: English
Weight: 202 KB
Volume: 25
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.091028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histomorphometric and μCT Analysis of Bo

Histomorphometric and μCT Analysis of Bone Biopsies From Postmenopausal Osteoporotic Women Treated With Strontium Ranelate

✍ Monique E Arlot; Yebin Jiang; Harry K Genant; Jenny Zhao; Brigitte Burt-Pichat; 📂 Article 📅 2007 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 348 KB

Comparative Effects of Teriparatide and

Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis

✍ Robert R Recker; Fernando Marin; Sophia Ish-Shalom; Rüdiger Möricke; Federico Ha 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 535 KB

Cost-effectiveness of strontium ranelate

Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years

✍ Mickaël Hiligsmann; Olivier Bruyère; Jean-Yves Reginster 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 318 KB

In osteoporotic women treated with stron

In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization

✍ G. Boivin; D. Farlay; M. T. Khebbab; X. Jaurand; P. D. Delmas; P. J. Meunier 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 454 KB

Results of two years therapy with stront

Results of two years therapy with strontium ranelate on bone mass and geometry in postmenopausal osteoporotic women. A peripheral quantitative computed tomography (pQCT) study

✍ K. Stathopoulos; P. Katsimbri; E. Atsali; G. Kiniklis; A.B. Zoubos; G. Skarantav 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Bone material properties in actively bon

Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid

✍ Sonja Gamsjaeger; Birgit Buchinger; Elizabeth Zwettler; Robert Recker; Dennis Bl 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 473 KB

Zoledronic acid (ZOL), a third-generation aminobisphosphonate, showed pronounced antifracture efficacy in a phase III clinical trial [Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly-Pivotal Fracture Trial (HORIZON-PFT)] when administered yearly (5-mg infusions of ZOL), produci